CJC -1295 Without DAC – IPA 5/5mg

Dual-peptide research blend combining CJC-1295 (without DAC) and Ipamorelin for in vitro investigation of GHRH receptor binding kinetics and endocrine signaling pathway dynamics in non-clinical models. For laboratory research use only. Not for human or animal use.

$60.00

Category: Research Peptides

Brand: BioBoost Labs+™

In stock

This research peptide blend contains CJC-1295 without DAC (5mg) and Ipamorelin (5mg) for a combined 10mg per vial. CJC-1295 is a tetra-substituted synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin is a synthetic pentapeptide with selective GHS-R1a receptor affinity. Together, these compounds are studied in non-clinical in vitro models for their interaction with GHRH and GHS receptor binding kinetics, intracellular signaling pathway dynamics, and endocrine cascade activity in controlled research environments.

For in vitro laboratory research use only. Not for human or animal use.

  • In vitro investigation of somatotropic axis signaling and peptide-receptor binding kinetics in non-clinical models
  • Analysis of pituitary GHRH receptor activation and downstream GH secretagogue pathway dynamics
  • Mechanistic studies of dual GHRH/GHS-R agonist synergy in controlled biochemical models
  • Exploration of growth hormone regulatory signaling and endocrine feedback pathway dynamics in vitro

Key Features:

  • Product Name: CJC-1295 Without DAC + Ipamorelin Blend

  • Components: CJC-1295 (No DAC) 5mg + Ipamorelin 5mg

  • Classification: Dual GHRH/GHRP research peptide blend

  • Form: Lyophilized peptide powder blend

  • Purity: ≥99.5% (HPLC-verified)

  • Storage: -20°C, protected from light and moisture

  • Supplied as: 5mg + 5mg per vial

  • Intended Use: In vitro laboratory research only. Not for human or animal use.

This product is intended strictly for laboratory research use only.
It is not for human consumption, diagnosis, treatment, or therapeutic use.
By purchasing, you confirm that the product will be used exclusively for lawful research.

COA-2026-RLRZDK CJC-1295 w/o DAC 5mg : Ipamorelin 5mg
COA261790 QC261696 CJC-1295 no Dac 5mg : Ipamorelin 5mg